Track 1:Pharmaceutical sciences

• Track 1-1Drug Screening and Discovery

• Track 1-2Pharmacological Testing

• Track 1-3Advances in Pharmaceutical Research

• Track 1-4R&D Advancement

• Track 1-5Principles of Good Manufacturing Practice

• Track 1-6Digital Pharma

Track 2:Medicinal Chemistry

• Track 2-1Identification and validation of drug targets

• Track 2-2Structural biology

• Track 2-3Drug ability of targets

• Track 2-4Drug design approaches

• Track 2-5Synthetic chemistry including combinatorial methods

• Track 2-6Bioorganic chemistry

Track 3:Pharmacology and Pharmacovigilance

• Track 3-1Cardiovascular Pharmacology

• Track 3-2Clinical pharmacology

• Track 3-3Neuropharmacology

• Track 3-4Psychopharmacology

• Track 3-5Systems Pharmacology

• Track 3-6Theoretical pharmacology

• Track 3-7Behavioral pharmacology

• Track 3-8Environmental pharmacology

• Track 3-9Ocular Pharmacology

• Track 3-10Biochemical Pharmacology

• Track 3-11Continental Pharmacovigilance

• Track 3-12Good Pharmacovigilance Practice

• Track 3-13Pharmacovigilance and Risk Management

Track 4:Chromatographic Techniques for Drug Analysis

• Track 4-1Flash column chromatography

• Track 4-2Paper chromatography

• Track 4-3Thin layer chromatography

• Track 4-4Displacement chromatography

• Track 4-5Hydrophobic interaction chromatography

• Track 4-6Reversed-phase chromatography

• Track 4-7Expanded bed adsorption chromatographic separation

• Track 4-8Chiral chromatography

Track 5:Synthetic Organic Chemistry

• Track 5-1Stereo controlled synthesis of complex organic molecules

• Track 5-2Organic synthesis and combinatorial chemistry

• Track 5-3Chemical methodologies, natural product synthesis, and chemical genomics

• Track 5-4Organic synthesis and natural products

Track 6:Bio Pharmaceuticals

• Track 6-1Pharmacokinetics and Pharmacodynamics

• Track 6-2Bioavailability and bioequivalence

• Track 6-3Bio waiver

• Track 6-4Biological Medicine

• Track 6-5Novel Approaches in Bio Pharmaceutics

• Track 6-6Invivo-invitro correlation

Track 7:Pharmacogenomics

• Track 7-1Translational Pharmacogenomics

• Track 7-2Applications of NGS to Pharmacogenomics

• Track 7-3Nutrigenomics

• Track 7-4Toxicogenomics

• Track 7-5Biomarker Translation and Testing

• Track 7-6Cancer Pharmacogenomics

• Track 7-7Pharmacogenitics & Individualized therapy

• Track 7-8Pharmacogenomics in Clinical Therapeutics

Track 8:Pharmacognosy and Phytochemistry

• Track 8-1Drugs from natural sources

• Track 8-2Molecular drug design

• Track 8-3Structure aided and computer aided drug design

• Track 8-4Telemedicine

Track 9:Pharmaceutical Toxicology

• Track 9-1Regulatory toxicology

• Track 9-2Analytical toxicology

• Track 9-3Plant toxicology

• Track 9-4Toxicologic Pathology

• Track 9-5Biodegradation

• Track 9-6Toxicokinetics

Track 10:Industrial Pharmacy

• Track 10-1Waste management

• Track 10-2Product management

• Track 10-3Post- marketing surveillance

• Track 10-4Good manufacturing practices

• Track 10-5Pharmaceutical Marketing

• Track 10-6Pharma Companies

• Track 10-7Pharma Manufacturing

Track 11:Regulatory Affairs

• Track 11-1Healthcare Regulatory Affairs

• Track 11-2Pharmaceutical RA

• Track 11-3Biologics and Biotechnology RA

• Track 11-4Medical devices RA

Track 12:Pharmaceutical Formulation

• Track 12-1Oral drugs

• Track 12-2Parental Formulations

• Track 12-3Topical Formulations

• Track 12-4Modified release Formulations

• Track 12-5Novel Drug Formulations

• Track 12-6Oncological Formulations

• Track 12-7Cosmetics

• Track 12-8Cosmetics

• Track 12-9Veterinary Products

Track 13:Computational Chemistry

• Track 13-1Ab initio methods

• Track 13-2Density functional methods

• Track 13-3Semi-empirical and empirical methods

• Track 13-4Molecular mechanics

• Track 13-5Chemical dynamics

• Track 13-6Molecular dynamics

Track 14:Nano Medicine

• Track 14-1Nano Materials

• Track 14-2Biological Devices

• Track 14-3Nano electronic Biosensors

• Track 14-4Nano Scale Materials

Track 15:Analytical and Bio Analytical Techniques

• Track 15-1Electro Analytical Methods

• Track 15-2Spectroscopy

• Track 15-3Electrophoresis

• Track 15-4Gravimetric analysis

• Track 15-5Ligand binding assays

• Track 15-6Mass spectrometry

• Track 15-7Nuclear Magnetic Resonance

Track 16:Drug designing and Drug Delivery

• Track 16-1Rational Drug Design

• Track 16-2Computer-aided drug design

• Track 16-3Structure-based drug design

• Track 16-4Dosage form

• Track 16-5Route of administration

Track 17:Clinical Pharmacy and Clinical Trials

• Track 17-1Clinical Pharmacy and Therapeutics

• Track 17-2Pre-Clinical and Clinical Trials

• Track 17-3Clinical Trials on Various Disorders

• Track 17-4Clinical Research and Statistics

• Track 17-5Clinical Pharmacy Activities and Prescriptions

• Track 17-6Clinical Pharmacy and Drug Reactions

• Track 17-7Dispensing Pharmacy and Research Chemists

Track 18:Intellectual Property Rights (IPR)

• Track 18-1Patents

• Track 18-2Copyright

• Track 18-3Industrial Design Rights

• Track 18-4Plant varieties

• Track 18-5Trademarks

• Track 18-6Trade dress

• Track 18-7Trade secrets